Precision medicine integrates genomics, biomarkers, and pharmacogenomics to tailor treatment to each patient.
Biomarker‑guided therapy improved outcomes in 25.9% of NCI‑MATCH substudies . It reduces side effects, improves accuracy, and helps detect resistance earlier through ctDNA monitoring.
Visit Banish Cancer Blog for more.








